There’s a quiet shift happening
PPIs used to be routine alongside steroids
Now clinicians are asking why
If there’s no clear benefit and real downside risk should we be using them at all?
🎧 Listen: https://t.co/UDswebDMCu
@RickyFrazer1@AOlssonBrown
#ImmunoOncology #MedicationSafety #Healthcare
Day 2 of the Immuno-Oncology Clinical Network national meeting in London continues with productive discussions focused on shaping a National Framework for the comprehensive management of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor immunotherapies.
Over the past two days, Clinicians Pharmacists and Nurses from across the UK have collaborated to share expertise, identify priorities, and explore how we can deliver safer, more consistent care for patients receiving immunotherapy treatments.
Our collective goal remains clear: to maximise the benefits of immunotherapy while reducing the risk of serious toxicity and improving outcomes for patients nationwide.
Thank you to everyone contributing their time, expertise, and commitment to this important work.
#Immunotherapy #ImmunoOncology #PatientSafety #CancerCare #irAEs #HealthcareCollaboration #Oncology #IOCN @AOlssonBrown@Youngdr100@JohnsonA_D@UKONSmember@BOPACommittee@immunobuddies@NHSEngland@nhs
🎙️ New Immunobuddies Episode Available!
Episode 196: The Role of Supportive Care in Optimising Immunotherapy and Cancer Outcomes – Part 1
In this latest episode, we’re joined by Dr Dan Monnery from the Clatterbridge Cancer Centre to discuss the evolving role of supportive care in cancer treatment and immunotherapy.
The conversation explores key aspects of patient support, multidisciplinary care, and approaches that can help improve patient experience and outcomes throughout treatment.
🎧 Tune in now to hear the discussion.
https://t.co/leEBLup24A
@RickyFrazer1@AOlssonBrown@VelindreCS@CCCNHS@IOClinicalNet@immunobuddies @UKAOSociety @UKONSmember@BOPACommittee@oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@OncEd@OncologyNT@myESMO@ASCO@OncoAlert
#Immunobuddies #Immunotherapy #SupportiveCare #CancerCare #Oncology #CancerOutcomes #HealthcarePodcast #MedEd #Clatterbridge #IOCN
📢 Today, we have made the decision to step down the universal mask-wearing across VCS.
We would like to extend our sincere thanks to all staff and patients for your cooperation and commitment to mask-wearing over recent months 💚
🎧 NEW PODCAST EPISODE – PART 1 OF 4
We’re kicking off a brand-new 4-part series on the Impact of Diet on Immunotherapy in the latest episode of the Immunobuddies Podcast.
In Part 1, we’re joined by Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby) to explore:
🥗 How diet interacts with the immune system
🦠 The role of the gut microbiome in immunotherapy
🧠 What the evidence really says (and what it doesn’t)
🩺 Practical, patient-centred dietary approaches during treatment
This series will break down nutrition, immunotherapy, and real-world clinical practice in a clear and practical way for healthcare professionals and patients alike.
🎙️ Listen now and stay tuned for Parts 2–4 coming soon. https://t.co/5yPCdGdJuP
@AOlssonBrown@RickyFrazer1@UHDBTrust@IOClinicalNet@immunobuddies@myESMO@ASCO@BOPACommittee@UKONSmember
@UKAOSociety @oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@VelindreCS@OncEd@OncologyNT
#Immunobuddies #Immunotherapy #Dieticians #OncologyNutrition #Microbiome #CancerCare #AlliedHealthProfessionals #PodcastSeries
🎟️Places are filling quickly for our next Case Conundrums Study Day in Bristol on March 27th 2026! Book now to avoid disapointment! 🎓🧬
🔗https://t.co/y5RPBmC0aw
🎙️ New Immunobuddies Mini-Series: Real-World Complex Cases 🚨
Ever wondered how experts navigate the trickiest immunotherapy scenarios in practice? 💭❓
Join Dr Ricky Frazer, Dr Anna Olsson-Brown, and guest Dr Jay Naik as they unpack real patient cases from the front line of immuno-oncology.
In this six-part special, the team explores:
⚖️ How to approach diagnostic uncertainty in immune-related toxicity
🧩 Lessons learned from complex, real-world decisions
🤝 The importance of multidisciplinary teamwork in patient care
These short, case-based episodes (around 20 minutes each) offer practical, honest insights you can apply in clinic — perfect for your next commute or coffee break ☕
🎧Catch-up on episodes now:
Episode 1: https://t.co/iIVCiK35UZ
Episode 2: https://t.co/6ud6pgSW2k
Episode 3: https://t.co/eh3MtjtmWK
#Immunobuddies #ImmunoOncology #Immunotherapy #MedicalPodcast #OncologyEducation #irAEs #CancerCare #ClinicalLearning
@RickyFrazer1@AOlssonBrown@IOClinicalNet@UKONSmember @UKAOSociety @BOPACommittee@myESMO@ASCO@ONCOassist@OncoViews@VelindreCS@HarrogateNHSFT@OncEd@OncologyNT
🚨🔊 New Podcast Episode – Immunobuddies Ep.159
🎙️ Triple Negative Breast Cancer: Role of Complete Pathological Response & Impact on Surgery
In this episode, we dive into:
✅ Why complete pathological response (pCR) matters in TNBC
✅ The challenges of toxicity and prolonged neutropenia on surgical planning
✅ Can some patients be cured with systemic therapy alone – and what does the future hold?
✅ The critical role of multidisciplinary decision-making to balance treatment, toxicity, and surgery
💡 Surgery remains the cornerstone of cure – but emerging data and patient experiences are pushing us to rethink pathways and future research.
Listen now 👉https://t.co/5Mnwl6rOBZ
#Immunobuddies #BreastCancer #Immunotherapy #Oncology #TripleNegativeBreastCancer #OncoTwitter #ImmunoOncology #Cancer #TNBC
@RickyFrazer1@AOlssonBrown@IOClinicalNet@UKONSmember @UKAOSociety @BOPACommittee@CRUKCamBreast@OncEd@OncologyNT@BreastCaupdates@BreastCaConnect@bctrcg@NHSBartsHealth@VelindreCS@myESMO@ASCO@ONCOassist@OncoViews
Join the NHS Wales Library Service and the NHS Wales E-Library for our literature searching webinar on Finding information using Embase. Aimed at those unconfident with literature searches or looking to refresh their skills.
Thursday July 3rd - 10am
https://t.co/ON5Q2R3ufp
📚 "You feel like you've been useful, and that you've made your mark"
At the end of March, we say a sad goodbye to Bernadette, who retires after 34 years as Velindre's librarian.
Read more about Bernadette's fascinating career: 🔗 https://t.co/nV8PtPzSOd
📢 #ThrowbackThursday with #ImmunoBuddies!
Back in early summer 2023, we ran a 3-part series diving into neurological toxicities & Guillain-Barré syndrome in immunotherapy with Dr Mark Willis. 🧠💡
Fast forward to now—join the IOCN webinar on Tuesday, 4th March at 6:30 PM for the latest insights on neurological toxicities! 🖥️🔬
Catch up with the podcasts here: https://t.co/mMOqNSZE3W
Sign up for the IOCN Webinar here: https://t.co/7khwXtwLgI
@IOClinicalNet@RickyFrazer1@AOlssonBrown
Pleased to share our latest validated search filters! The NICE AI medical device intervention filters (MEDLINE & Embase, Ovid) retrieve evidence about the interventions effectively and reliably: https://t.co/Ro3A90KyXj
#medlibs#ukmedlibs#canmedlibs#ausmedlibs @ISSG_Filters
THE BEST WEEK OF MY CAREER! Witnessing first hand the delivery of TILs in NIK. So excited to support bringing TILs to treat Solid Tumours for the first time in Wales and working to ensure our Welsh patients can access these treatment as they are approved! @MoondanceCancer
The JBI Manual for Evidence Synthesis has added a new chapter, 'Search Methodology for JBI Evidence Syntheses', providing essential guidance for academics and researchers to conduct systematic reviews and scoping reviews👉 https://t.co/ADL0rxLlrO #JBIEBHC